Related Experiment Video
Updated: Aug 8, 2026

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children
Published on: August 22, 2012
[Anthelmintics as a risk factor in intestinal obstruction by Ascaris lumbricoides in children]
O Vásquez Tsuji1, P Gutiérrez Castrellón, M A Yamazaki Nakashimada
1Servicio de Parasitología y Micología, Instituto Nacional de Pediatría, Avenida Insurgentes Sur 3700.-C. Colonia Insurgentes Cuicuilco, Código Postal 04530, Delegación Coyoacán, México, Distrito Federal.
Insights
Prior anthelmintic drug use, especially mebendazole, significantly increases the risk of intestinal obstruction in children with ascariasis. This finding highlights the need for careful consideration of medication timing and type in managing parasitic infections.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Pharmacology
Context:
- Ascariasis, caused by Ascaris lumbricoides, is a common helminthic infection globally.
- Intestinal obstruction is a severe complication of ascariasis, particularly in children.
- The role of anthelmintic drugs as a potential risk factor for this complication requires investigation.
Purpose:
- To evaluate the association between anthelmintic drug use and the risk of intestinal obstruction in children diagnosed with ascariasis.
- To identify specific anthelmintic medications and treatment timings that may contribute to intestinal obstruction.
- To establish a multivariate predictive risk model for intestinal obstruction in pediatric ascariasis.
Summary:
- A retrospective study analyzed 199 children hospitalized for intestinal ascariasis.
- Children who developed intestinal obstruction (Group A, n=66) were compared to those without complications (Group B, n=133).
- Prior anthelmintic treatment, particularly mebendazole, was identified as a significant risk factor for intestinal obstruction.
Impact:
- Findings suggest that the timing and type of anthelmintic medication, especially mebendazole, are critical factors in the development of intestinal obstruction in ascariasis.
- This research informs clinical practice regarding the safe and effective management of ascariasis in pediatric populations.
- The study provides a predictive risk model that can aid in identifying children at higher risk for developing intestinal obstruction.
Abstract:
In a retrospective study the authors analyzed the clinical records of 199 children ages one month to 16 years hospitalized, with the diagnosis of intestinal ascariasis, in the Instituto Nacional de Pediatria of Mexico from 1984 to 1999. The purpose of the study was to evaluate the use of anthelmintics drugs as a risk factor of intestinal obstruction by A. lumbricoides. Two groups were made for the study: Group A (n = 66) of children who presented intestinal obstruction, Group B (n = 133) children with no complications. A comparative analysis of clinical data of both groups was made by means of chi square with Yates correction and a stratified analysis by means of chi square. Possible confusing elements were overcrowding, age and the use of antiparasitic drugs. The calculus of risk factors for intestinal obstruction by A. lumbricoides was done by means of contingency tables of 2 x 2 and odds ratio with an IC of 95%. The significant risk factors were included in a model of logistics regression with an impact variable consting in the presence or absence of intestinal obstruction in order to establish a multivariate model of predictive risk at level of significance of p < 0.05. Twenty-seven patients (40.90%) in group A (n = 66) were given anthelmintics medications prior to the intestinal obstruction: mebendazol, 14 (51-85%); two, albedazol (7.4%); eight, a non-specified anthelmintic (29.6%). In addition, an anthelmintic medication without a specified time of ingestion: two with mebendazol and one with piperazine (11.3%). In the case of mebendazol, the drug most frequently associated with intestinal obstruction, seven patients received it on the same day of the obstruction; five patients received it between one and seven days prior to the obstruction; two received it seven days prior to the complication. In the control group, only 7% had taken the anthelmintic one to seven days before the diagnosis of uncomplicated intestinal ascariasis diagnosis was made. With the step by step (Backward) logistic regression conditioned by the treatment variable with an anthelmintic, an X2 = 38.15 gl, p < 0.000 was obtained for which reason it was considered by A. lumbricoides. Of the probable risk factors analyzed in this study, the only one capable of influencing and predicting the presentation of intestinal obstruction by A. lumbricoides in children, was the prior anthelmintic treatment particularly with mebendazol.
More Related Videos
03:46A Simple Fecal Flotation Method for Diagnosing Zoonotic Nematodes Under Field and Laboratory Conditions
Published on: December 15, 2023
04:57Comparative Analysis of Automatic Fecal Analyzer versus Direct Wet Smear Microscopy for Detecting Parasitic Infections in Stool Samples
Published on: April 25, 2025
Related Concept Videos
Giardiasis
Amebiasis
Anthelminthic Agents
Intestinal Obstruction I: Introduction
Intestinal Obstruction II: Pathophysiology
Appendicitis